KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Gains from Investment Securities (2016 - 2025)

Clorox (CLX) has 16 years of Gains from Investment Securities data on record, last reported at -$13.0 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 160.0% year-over-year to -$13.0 million; the TTM value through Dec 2025 reached $268.0 million, up 1318.18%, while the annual FY2025 figure was $264.0 million, N/A changed from the prior year.
  • Gains from Investment Securities reached -$13.0 million in Q4 2025 per CLX's latest filing, down from $12.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $255.0 million in Q2 2025 and bottomed at -$13.0 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $36.5 million, with a median of -$1.0 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: soared 2172.73% in 2021, then crashed 900.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$1.0 million in 2021, then changed by 0.0% to -$1.0 million in 2022, then crashed by 600.0% to -$7.0 million in 2023, then increased by 28.57% to -$5.0 million in 2024, then crashed by 160.0% to -$13.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$13.0 million in Q4 2025, $12.0 million in Q3 2025, and $255.0 million in Q2 2025.